Distinguished Scientist, Pharmacokinetics

MSD•Boston, MA
•$210,400 - $331,100•Hybrid

About The Position

The Department of Pharmacokinetics, Dynamics, Metabolism and Bioanalytics (PDMB) is seeking a Distinguished Scientist to serve as a Drug Metabolism and Pharmacokinetics (DMPK) submission expert. This leader will support the development pipeline and ensure high-quality nonclinical pharmacokinetics filings from first-in-human studies through marketing applications and lifecycle management. The role contributes to PDMB portfolio support strategy and DMPK priorities across therapeutic areas and modalities. The Distinguished Scientist ensures submission packages are robust and aligned with program objectives, and presents drug disposition properties in the context of benefit-risk and drug-interaction potential in target populations, within regulatory guidelines. As a member of the DMPK Leadership team, the Distinguished Scientist will help influence portfolio decisions, contribute to regulatory filings, labeling discussions, and approvals, and contribute to global scientific and portfolio strategy and talent development. The position calls for exemplary ways of working, strong ethics, negotiation skills, and an enterprise mindset.

Requirements

  • PhD or M.Sci. in Pharmaceutical Sciences, Pharmacology, or a related field.
  • At least 15 years of DMPK experience, including extensive experience as a team representative in drug discovery and development programs.
  • Strong scientific acumen and understanding of drug development processes and relevant regulatory guidelines, with a track record of supporting clinical candidates and first-in-human execution.
  • Experience collaborating with and mentoring program team representatives on a range of nonclinical and clinical issues.
  • Strong leadership skills and ability to collaborate with and influence scientists across scientific disciplines and influence strategic direction.
  • Efficient organizational skills and excellent verbal and written communication skills, including the ability to develop and deliver clear, concise documents and presentations.
  • Experience authoring and critically reviewing nonclinical PK packages and clinical sections of regulatory documents, including IBs, INDs, CTAs, NDAs, BLAs, MAAs, PIP/PSPs, Scientific Advice, weight-of-evidence risk assessments, regulatory responses, and product labels.
  • Demonstrated experience navigating issues and regulatory requirements for advancing drug development candidates across modalities from preclinical through Phase 4, regulatory approvals, and/or post-approval commitments.
  • Required skills include drug development, drug metabolism, pharmacokinetics, portfolio strategies, regulatory filings, regulatory strategies, regulatory submissions, scientific leadership, and small molecules.

Nice To Haves

  • Extensive experience in early development and product development teams.
  • Experience in Scientific Advisory Committee meetings with the FDA and/or other regulatory agencies.
  • Deep understanding of filing and labeling requirements across major world markets.

Responsibilities

  • Monitor late-stage development and post-marketing programs to ensure nonclinical packages supporting original marketing applications and supplemental applications are robust, timely, aligned with filing strategy, and consistent with clinical safety and efficacy positions.
  • Represent PDMB on Label Approval Strategy Teams and in other discussions or teams requiring DMPK expertise, including clinical safety and risk management, nonclinical safety mechanistic investigations related to filings, ICH guidance, and label updates.
  • Review investigator brochures, clinical trial applications, INDs, NDAs, regulatory responses, and other legal and scientific documents supporting global clinical trials and registration.
  • Provide scientific and strategic oversight for development candidates across therapeutic areas in collaboration with PDMB representatives, subject-matter experts, management, and partners in other functions to align regulatory strategy and input into mechanistic investigations.
  • Contribute to Clinical Pharmacology strategy discussions, including starting dose, dose escalation, timing, design and interpretation of Phase 1 studies, drug interactions, special populations, and human ADME studies, using nonclinical data generated by PDMB.
  • Ensure DMPK data and documentation practices maintain quality as regulatory expectations change across countries and regions.
  • Lead internal and cross-departmental initiatives to improve policies, procedures, and strategic direction in line with company portfolio strategy and regulatory expectations.
  • Oversee and/or conduct critical due diligence reviews for in-licensing assets across therapeutic areas and serve as an integration lead.
  • Serve as program representative for high-priority development programs.
  • Develop future leaders and build organizational experience in drug development, regulatory processes, risk assessments, and regulatory guidelines.

Benefits

  • Medical, dental, and vision healthcare benefits.
  • Other insurance benefits for employees and families.
  • Retirement benefits, including 401(k).
  • Paid holidays.
  • Vacation.
  • Compassionate and sick days.
  • Annual bonus and long-term incentive, if applicable.

Stand Out From the Crowd

Upload your resume and get instant feedback on how well it matches this job.

Upload and Match Resume

What This Job Offers

Job Type

Full-time

Career Level

Senior

Education Level

Ph.D. or professional degree

© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service